BioAI Announces Strategic Partnership with Arbele Bio to advance Predictive AI-Models in Oncology Clinical Trials
recent articles
Closing 100 Year-Old Missing Link: Dramatically Improves Pathology Workflow with Intelligent Robotics and Utilizes Proprietary Inputs for Next-Gen Precision Medicine & Care Paradigms HAWTHORNE, N.Y., Nov. 18, 2021 (GLOBE NEWSWIRE)...
A research team at Dartmouth-Hitchcock led by Audrey H. Calderwood, MD, MS, director of the Comprehensive Gastroenterology Center, and associate professor of medicine at Geisel School of Medicine at Dartmouth and the Dartmouth Institute for...
Pfizer Says Its COVID-19 Pill Reduces Death, Hospitalization Risk by 89%; Will Submit for FDA Approval Pfizer says that its COVID-19 pill reduced the risk of hospitalization or death by 89 percent in a clinical trial involving adults “at...
Aiforia announces the CE-IVD mark of its Aiforia® Clinical AI Model for Lung Cancer; PD-L1 for assisting pathologists in the fast and accurate primary diagnosis of lung cancer. This latest AI model expands Aiforia’s portfolio of clinical...
Using Artificial Intelligence to support Quantitative Digital Pathology in R&D DATE & TIME Wednesday 17th November @ 4:00pm GMT / 11:00am EST / 8:00am PST Register Now What you'll learn: This free session will be presented by...
The AI achieved 100% sensitivity and 50% or more specificity TOKYO, (November 16, 2021)—The results of Olympus’ ongoing joint research program1to create an AI-based pathology diagnostic tool with the potential to streamline...
